• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Clinical trials

Tucidinostat, a promising therapeutic option for R/R peripheral T-cell lymphoma

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Restoring the delicate coagulation balance in haemophilia
  • Non-myeloablative haploidentical haematopoietic stem cell transplantation for adult patients with sickle cell disease: Current status and future perspectives
  • Unveiling cytokine profiles: HLH induced by the combination of cemiplimab and venetoclax
  • Clinical importance of screening for the neglected acquired von Willebrand syndrome in patients with myeloproliferative neoplasms: A case series
  • Journal scan
  • New haematology reimbursements in Belgium
Clinical trials

Ide-cel outperforms standard regimens in triple-class-exposed R/R multiple myeloma

Read more
Clinical trials

Dabrafenib plus trametinib induces durable responses in BRAF-mutated hairy cell leukaemia

Read more
Clinical trials

Gene therapy for haemophilia A with valoctogene roxaparvovec

Read more
Clinical trials

Efficacy and safety of emicizumab demonstrated in people with mild or moderate haemophilia A

Read more
Clinical trials

Adding daratumumab to bortezomib-dexamethasone improves survival in myeloma patients

Read more
Clinical trials

G-CSF, decitabine and busulfan-cyclophosphamide conditioning for MDS and secondary AML

Read more
Clinical trials

KRd regimen after stem cell transplantation delays disease progression in multiple myeloma

Read more
Clinical trials

Enasitenib outperforms conventional care in pretreated older IDH2-mutant R/R AML patients

Read more
Previous 3 4 5 6 7 8 9 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025